The use of propolis for mastitis control

Bibliographic Details
Main Author: Laranjo, Marta
Publication Date: 2019
Other Authors: Andrade, Nara, Queiroga, Maria Cristina
Language: por
Source: Repositórios Científicos de Acesso Aberto de Portugal (RCAAP)
Download full: http://hdl.handle.net/10174/25982
Summary: Propolis is a resinous mass produced by honeybees for the protection of the honeycomb. Propolis has become very popular in Europe due to its antibacterial activity. Recently, propolis activity against bacterial biofilms was reported. Mastitis control greatly depends on the use of antimicrobials. Antimicrobial resistance and bacterial ability to produce biofilm increase microbial survival and contribute to pathogens’ persistence in the farm. Furthermore, the transfer of resistance genes from mastitis causing pathogens to bacteria belonging to the human natural microbiota fully justifies the search for alternative products with antimicrobial activity. The aim of this study was to assess propolis components accountable for bactericidal and antibiofilm activities against Staphylococcus spp. isolated from the milk of sheep and goats with mastitis. Ten propolis batches (seven from Brazil and three from Portugal) were collected in different regions and were used to produce 30% propolis ethanol extracts (PEE). Total phenolics, flavonoids, anthocyanins and condensed tannins contents were assessed. Thirty-five Staphylococcus aureus and 104 coagulase-negative staphylococci (CNS) were analysed for in vitro susceptibility to PEE and minimum bactericidal concentration (MBC) was performed with a 96-pins microplate replicator. These PEE were also assessed for biofilm formation inhibition and biofilm disruption on 44 biofilm producing Staphylococcus isolates. To identify the propolis components, which are probably associated with antimicrobial and antibiofilm activities, statistical analyses were performed. Total phenolics content varied from 67.62 to 365.42 mg GAE/g extract, flavonoids content from 54.82 to 140.6 mg QE/g extract, anthocyanins content between not detected and 8.39 mg/g extract, and condensed tannins content between 36.92 and 3766.16 mg ECC/g DP extract. All 139 staphylococci analysed (100%) showed to be susceptible to all PEE, but Brown4, with concentrations varying between 0.026 and 13.37 mg/mL. Concerning antibiofilm activity, nine PEEs inhibited biofilm formation in most of the 44 biofilm-forming isolates. The mean inhibition percentage for each PEE, varied between 33.5 and 80.2%. Regarding biofilm disruption, all ten PEE partially or totally destroyed the biofilm produced by all 44 staphylococci isolates. The mean PEE activity on biofilm disruption varied between 28.4 and 79.5%. According to these results, propolis deserves to be considered for the control of mastitis.
id RCAP_f7f081683f94d337ea0300328a406ea3
oai_identifier_str oai:dspace.uevora.pt:10174/25982
network_acronym_str RCAP
network_name_str Repositórios Científicos de Acesso Aberto de Portugal (RCAAP)
repository_id_str https://opendoar.ac.uk/repository/7160
spelling The use of propolis for mastitis controlantibiofilmantimicrobialmastitispropolisPropolis is a resinous mass produced by honeybees for the protection of the honeycomb. Propolis has become very popular in Europe due to its antibacterial activity. Recently, propolis activity against bacterial biofilms was reported. Mastitis control greatly depends on the use of antimicrobials. Antimicrobial resistance and bacterial ability to produce biofilm increase microbial survival and contribute to pathogens’ persistence in the farm. Furthermore, the transfer of resistance genes from mastitis causing pathogens to bacteria belonging to the human natural microbiota fully justifies the search for alternative products with antimicrobial activity. The aim of this study was to assess propolis components accountable for bactericidal and antibiofilm activities against Staphylococcus spp. isolated from the milk of sheep and goats with mastitis. Ten propolis batches (seven from Brazil and three from Portugal) were collected in different regions and were used to produce 30% propolis ethanol extracts (PEE). Total phenolics, flavonoids, anthocyanins and condensed tannins contents were assessed. Thirty-five Staphylococcus aureus and 104 coagulase-negative staphylococci (CNS) were analysed for in vitro susceptibility to PEE and minimum bactericidal concentration (MBC) was performed with a 96-pins microplate replicator. These PEE were also assessed for biofilm formation inhibition and biofilm disruption on 44 biofilm producing Staphylococcus isolates. To identify the propolis components, which are probably associated with antimicrobial and antibiofilm activities, statistical analyses were performed. Total phenolics content varied from 67.62 to 365.42 mg GAE/g extract, flavonoids content from 54.82 to 140.6 mg QE/g extract, anthocyanins content between not detected and 8.39 mg/g extract, and condensed tannins content between 36.92 and 3766.16 mg ECC/g DP extract. All 139 staphylococci analysed (100%) showed to be susceptible to all PEE, but Brown4, with concentrations varying between 0.026 and 13.37 mg/mL. Concerning antibiofilm activity, nine PEEs inhibited biofilm formation in most of the 44 biofilm-forming isolates. The mean inhibition percentage for each PEE, varied between 33.5 and 80.2%. Regarding biofilm disruption, all ten PEE partially or totally destroyed the biofilm produced by all 44 staphylococci isolates. The mean PEE activity on biofilm disruption varied between 28.4 and 79.5%. According to these results, propolis deserves to be considered for the control of mastitis.Nova Science Publishers, Inc., New York, USA2019-11-06T10:43:06Z2019-11-062019-01-01T00:00:00Zbook partinfo:eu-repo/semantics/publishedVersionhttp://hdl.handle.net/10174/25982http://hdl.handle.net/10174/25982porLaranjo, M., Andrade, N., Silva, T. M. S. and Queiroga, M. C. (2019) “The use of propolis for mastitis control.”, Chapter 6, pp. . In “Mastitis: Symptoms, Triggers and Treatment”. Edited by Tapas Kumar Sar, Nova Science Publishers, Inc., New York, USA. ISBN 978-1-53616-124-3. Aceite para publicação. https://novapublishers.com/shop/mastitis-symptoms-triggers-and-treatment/https://novapublishers.com/shop/mastitis-symptoms-triggers-and-treatment/mlaranjo@uevora.ptndcrique@uevora.pt384Laranjo, MartaAndrade, NaraQueiroga, Maria Cristinainfo:eu-repo/semantics/embargoedAccessreponame:Repositórios Científicos de Acesso Aberto de Portugal (RCAAP)instname:FCCN, serviços digitais da FCT – Fundação para a Ciência e a Tecnologiainstacron:RCAAP2025-02-25T01:51:27Zoai:dspace.uevora.pt:10174/25982Portal AgregadorONGhttps://www.rcaap.pt/oai/openaireinfo@rcaap.ptopendoar:https://opendoar.ac.uk/repository/71602025-05-28T12:19:27.413997Repositórios Científicos de Acesso Aberto de Portugal (RCAAP) - FCCN, serviços digitais da FCT – Fundação para a Ciência e a Tecnologiafalse
dc.title.none.fl_str_mv The use of propolis for mastitis control
title The use of propolis for mastitis control
spellingShingle The use of propolis for mastitis control
Laranjo, Marta
antibiofilm
antimicrobial
mastitis
propolis
title_short The use of propolis for mastitis control
title_full The use of propolis for mastitis control
title_fullStr The use of propolis for mastitis control
title_full_unstemmed The use of propolis for mastitis control
title_sort The use of propolis for mastitis control
author Laranjo, Marta
author_facet Laranjo, Marta
Andrade, Nara
Queiroga, Maria Cristina
author_role author
author2 Andrade, Nara
Queiroga, Maria Cristina
author2_role author
author
dc.contributor.author.fl_str_mv Laranjo, Marta
Andrade, Nara
Queiroga, Maria Cristina
dc.subject.por.fl_str_mv antibiofilm
antimicrobial
mastitis
propolis
topic antibiofilm
antimicrobial
mastitis
propolis
description Propolis is a resinous mass produced by honeybees for the protection of the honeycomb. Propolis has become very popular in Europe due to its antibacterial activity. Recently, propolis activity against bacterial biofilms was reported. Mastitis control greatly depends on the use of antimicrobials. Antimicrobial resistance and bacterial ability to produce biofilm increase microbial survival and contribute to pathogens’ persistence in the farm. Furthermore, the transfer of resistance genes from mastitis causing pathogens to bacteria belonging to the human natural microbiota fully justifies the search for alternative products with antimicrobial activity. The aim of this study was to assess propolis components accountable for bactericidal and antibiofilm activities against Staphylococcus spp. isolated from the milk of sheep and goats with mastitis. Ten propolis batches (seven from Brazil and three from Portugal) were collected in different regions and were used to produce 30% propolis ethanol extracts (PEE). Total phenolics, flavonoids, anthocyanins and condensed tannins contents were assessed. Thirty-five Staphylococcus aureus and 104 coagulase-negative staphylococci (CNS) were analysed for in vitro susceptibility to PEE and minimum bactericidal concentration (MBC) was performed with a 96-pins microplate replicator. These PEE were also assessed for biofilm formation inhibition and biofilm disruption on 44 biofilm producing Staphylococcus isolates. To identify the propolis components, which are probably associated with antimicrobial and antibiofilm activities, statistical analyses were performed. Total phenolics content varied from 67.62 to 365.42 mg GAE/g extract, flavonoids content from 54.82 to 140.6 mg QE/g extract, anthocyanins content between not detected and 8.39 mg/g extract, and condensed tannins content between 36.92 and 3766.16 mg ECC/g DP extract. All 139 staphylococci analysed (100%) showed to be susceptible to all PEE, but Brown4, with concentrations varying between 0.026 and 13.37 mg/mL. Concerning antibiofilm activity, nine PEEs inhibited biofilm formation in most of the 44 biofilm-forming isolates. The mean inhibition percentage for each PEE, varied between 33.5 and 80.2%. Regarding biofilm disruption, all ten PEE partially or totally destroyed the biofilm produced by all 44 staphylococci isolates. The mean PEE activity on biofilm disruption varied between 28.4 and 79.5%. According to these results, propolis deserves to be considered for the control of mastitis.
publishDate 2019
dc.date.none.fl_str_mv 2019-11-06T10:43:06Z
2019-11-06
2019-01-01T00:00:00Z
dc.type.driver.fl_str_mv book part
dc.type.status.fl_str_mv info:eu-repo/semantics/publishedVersion
status_str publishedVersion
dc.identifier.uri.fl_str_mv http://hdl.handle.net/10174/25982
http://hdl.handle.net/10174/25982
url http://hdl.handle.net/10174/25982
dc.language.iso.fl_str_mv por
language por
dc.relation.none.fl_str_mv Laranjo, M., Andrade, N., Silva, T. M. S. and Queiroga, M. C. (2019) “The use of propolis for mastitis control.”, Chapter 6, pp. . In “Mastitis: Symptoms, Triggers and Treatment”. Edited by Tapas Kumar Sar, Nova Science Publishers, Inc., New York, USA. ISBN 978-1-53616-124-3. Aceite para publicação. https://novapublishers.com/shop/mastitis-symptoms-triggers-and-treatment/
https://novapublishers.com/shop/mastitis-symptoms-triggers-and-treatment/
mlaranjo@uevora.pt
nd
crique@uevora.pt
384
dc.rights.driver.fl_str_mv info:eu-repo/semantics/embargoedAccess
eu_rights_str_mv embargoedAccess
dc.publisher.none.fl_str_mv Nova Science Publishers, Inc., New York, USA
publisher.none.fl_str_mv Nova Science Publishers, Inc., New York, USA
dc.source.none.fl_str_mv reponame:Repositórios Científicos de Acesso Aberto de Portugal (RCAAP)
instname:FCCN, serviços digitais da FCT – Fundação para a Ciência e a Tecnologia
instacron:RCAAP
instname_str FCCN, serviços digitais da FCT – Fundação para a Ciência e a Tecnologia
instacron_str RCAAP
institution RCAAP
reponame_str Repositórios Científicos de Acesso Aberto de Portugal (RCAAP)
collection Repositórios Científicos de Acesso Aberto de Portugal (RCAAP)
repository.name.fl_str_mv Repositórios Científicos de Acesso Aberto de Portugal (RCAAP) - FCCN, serviços digitais da FCT – Fundação para a Ciência e a Tecnologia
repository.mail.fl_str_mv info@rcaap.pt
_version_ 1833592727466409984